Zymeworks (ZYME) EBIT Growth (1y) (2022 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) EBIT Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -36.55% |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 99.51% |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - | -6,158.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,158.16% |
| Mar 31, 2026 | -83.96% |
| Dec 31, 2025 | -98.73% |
| Sep 30, 2025 | 35.36% |
| Jun 30, 2025 | 98.43% |
| Mar 31, 2025 | 32.24% |
| Dec 31, 2024 | 5.14% |
| Sep 30, 2024 | -2.91% |
| Jun 30, 2024 | 20.75% |
| Mar 31, 2024 | -38.57% |
| Dec 31, 2023 | -107.33% |
| Sep 30, 2023 | 34.00% |
| Jun 30, 2023 | 17.79% |
| Mar 31, 2023 | 62.47% |
| Dec 31, 2022 | 881.89% |
| Sep 30, 2022 | 17.40% |